LLIVE: A non-interventional multicenter study of first-line Avastin® (bevacizumab) in combination with chemotherapy in patients with metastatic colorectal cancer in Lebanon

被引：0
|
作者：
Ali, Shamseddine [1 ]
Sarah, Abdel Massih [1 ]
George, Chahine [2 ]
Fadi, Nasr [3 ]
Joseph, Kattan [4 ]
Fadi, Farhat [5 ]
Bassim, Kobrossy [6 ]
Dany, Abi Gerges [7 ]
Walid, Moukadem [8 ]
Chadi, Saba [9 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
[2] Hotel Dieu de France, Beirut, Lebanon
[3] Mt Lebanon Hosp, Beirut, Lebanon
[4] St Joseph Hosp, Beirut, Lebanon
[5] Hammoud Hosp Univ, Med Ctr, Saida, Lebanon
[6] St George Hosp Univ, Med Ctr, Beirut, Lebanon
[7] Middle East Inst Hlth, Bsalim, Lebanon
[8] Haykal Hosp Tripoli, Tripoli, Lebanon
[9] Roche, Beirut, Lebanon
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-306
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Non-Interventional Multicenter Study of First-Line Bevacizumab in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer in Lebanon
    Temraz, Sally
    Nasr, Fadi
    Kattan, Joseph
    Abigerges, Dany
    Moukadem, Walid
    Farhat, Fadi
    Maatouk, Layal
    Chahine, Georges
    Shamseddine, Ali
    BIOLOGICS-TARGETS & THERAPY, 2022, 16 : 7 - 15
  • [2] Bevacizumab in combination with chemotherapy: First-line treatment of patients with metastatic colorectal cancer
    Hochster, Howard S.
    SEMINARS IN ONCOLOGY, 2006, 33 (05) : S8 - S14
  • [3] BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY FOR THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
    Ubago, R.
    Castillo, M. A.
    Flores, S.
    Beltran, C.
    VALUE IN HEALTH, 2011, 14 (07) : A435 - A435
  • [4] First-line bevacizumab and beyond first progression in metastatic Colorectal Carcinoma (mCRC): The KORALLE non-interventional study
    Arnold, D.
    Eggers, E.
    Uhlig, J.
    Reichert, D.
    Becker, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 130 - 130
  • [5] Treatment of Metastatic Colorectal Carcinoma with Bevacizumab in First-Line and beyond First Progression: The KORALLE Non-Interventional Cohort Study
    Arnold, Dirk
    Eggers, Egbert
    Uhlig, Jens
    Reichert, Dietmar
    Becker, Lars
    Thiebach, Lars
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (10) : 576 - 586
  • [6] Bevacizumab in combination with first-line chemotherapy in patients with metastatic colorectal cancer: a meta-analysis
    Hu, W.
    Xu, W. -S.
    Liao, X. -F.
    He, H. -J.
    MINERVA CHIRURGICA, 2015, 70 (06) : 451 - 458
  • [7] Combination of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: Slovakian experience
    Salek, T.
    Mego, M.
    Mardiak, J.
    Andrasina, I.
    Spanik, S.
    Malec, V.
    Barilla, R.
    Riedelova, K.
    Benedikty, A.
    Dammak, A.
    Porsok, S.
    Svabova, V.
    Chovanec, M.
    Cipkova, A.
    Usakova, V.
    Siskova, M.
    Jurisova, S.
    Dolinsky, J.
    Hlavata, Z.
    Andrezalova, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Bevacizumab in combination with chemotherapy in the first-line treatment of metastatic colorectal carcinoma
    Usakova, V.
    Sevcikova, K.
    Usak, J.
    Bartosova, Z.
    Mikulova, M.
    Spanik, S.
    NEOPLASMA, 2013, 60 (01) : 83 - 91
  • [9] Addition of Bevacizumab to First-Line Chemotherapy for Metastatic Colorectal Cancer
    Tsutsumi, Soichi
    Fujii, Takaaki
    Yamaguchi, Satoru
    Suto, Toshinaga
    Yajima, Reina
    Morita, Hiroki
    Kato, Toshihide
    Asao, Takayuki
    Kuwano, Hiroyuki
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 633 - 637
  • [10] Bevacizumab (bev) combined with chemotherapy as first-line treatment in patients (pts) with metastatic colorectal cancer: Final results from a large non-interventional, community-based study
    Hildebrandt, B.
    Bruch, H. -R
    Zimber, J.
    Hahn, L.
    Lueck, A.
    Timmer, H.
    Kroening, H.
    Tondar, S.
    Kutscheidt, A.
    Broszeit-Luft, S.
    Oncology Research and Treatment, 2015, 38 : 205 - 206
12345